Evidence map›Paper›PMID 41743620›Full record

ArticleInternational journal of women's health2026

Chylous Lymphocyst Following Retroperitoneal Lymphadenectomy: A Case Report and Review of Treatment.

Hathaipat Sukjariangporn, Man Thongaram, Ruai Kittikhun, Jidapa Samrarn, Thanita Wetcho, Nuttavut Kantathavorn

Abstract readCase Reports
In one paragraph

Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hathaipat SukjariangpornDepartment of Obstetrics and Gynecology, Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.ORCID 0009-0000-2472-049X
Man ThongaramDepartment of Obstetrics and Gynecology, Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
Ruai KittikhunDepartment of Obstetrics and Gynecology, Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
Jidapa SamrarnDepartment of Obstetrics and Gynecology, Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.ORCID 0000-0003-0710-8105
Thanita WetchoDepartment of Obstetrics and Gynecology, Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
Nuttavut KantathavornPrincess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.ORCID 0000-0002-2056-866X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chylous lymphocyst or lymphocele following pelvic and para-aortic lymphadenectomy is rare. Clinically, patients usually present with abdominal distension or abdominal pain. The milky appearance of the cystic fluid reflects its high triglyceride content. Although specific guidelines for managing chylous lymphocyst are limited, the approaches used for chylous ascites can generally be applied. More than 70% of patients respond to conservative treatment, which includes a modified diet consisting of high protein, fat restriction, and medium-chain triglyceride supplementation. We present the case of a 45-year-old woman who developed a symptomatic 15-cm pelvic lymphocyst one month after surgical staging for a mucinous borderline ovarian tumor. Following the placement of a percutaneous catheter drainage (PCD), the initial output was 300-400 mL/day of clear serous fluid. Notably, a delayed chylous conversion occurred on the 20th day of drainage, the fluid turned milky and biochemical analysis confirmed a triglyceride level of 493 mg/dL. Initiation of a modified high-protein, fat-restricted diet resulted in a rapid decrease in drainage volume to 30 mL/day within 24 hours, alongside a return to clear yellowish appearance. This study aims to report the clinical manifestations and to summarize current therapeutic options for patients with chylous leakage.

Indexed as

chylomachylous lymphocystlymphoceleovarian cancerretroperitoneal lymphadenectomy

Identifiers

PMID41743620
PMCPMC12931131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.